THE FEATURES OF NEUROIMMUNE ENDOCRINE AND GERIATRIC STATUS IN PATIENTS WITH CORONARY ARTERY DISEASE SCHEDULED CORONARY ARTERY BYPASS SURGERY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents an overview of the features of neuroimmunoendocrine and geriatric status in patients with coronary heart disease, which are scheduled on a planned coronary artery bypass grafting. The possible effect of the dynamics of proinflammatory immune response on the development of adverse events in such patients is described. It is shown that the frailty syndrome and the main geriatric syndromes can be predictors of adverse events after a planned coronary artery bypass grafting. The data of recent studies on biomarkers of fatal and nonfatal complications, as well as innovative developments of ways to identify the risks of adverse events in such patients are presented.

Full Text

Restricted Access

About the authors

A. Khmelnitsky

Saint-Petersburg Institute of Bioregulation and gerontology

Email: ibg@gerontology.ru
Candidate of Medical Sciences

K. Prashchayeu

Federal scientific and clinical center of specialized types of medical care and medical technologies of the Federal medical and biological Agency

Email: ibg@gerontology.ru

D. Elistratov

OOO Parafarm

Email: ibg@gerontology.ru
Penza

References

  1. Ильницкий А.Н., Прощаев К.И., Варавина Л.Ю. и др. Старческая астения (frailty): оксидативные и нейроиммуноэндокринные изменения // Российский семейный врач. - 2013; 2: 37-41
  2. Goto T., Maekawa K. Cerebral dysfunction after coronary artery bypass surgery // J. Anesth. - 2014; 28 (2): 242-8
  3. Шаленкова М.А., Мухаметова Э.Т. Роль маркеров некроза и воспаления в прогнозировании острых форм ишемической болезни сердца // Клиническая медицина. - 2013; 11: 14-20
  4. Pustavoitau A., Barodka V., Sharpless N. et al. Role of senescence marker p16NK4a measured in peripheral blood T-lymphocytes in predicting length of hospital stay after coronary artery bypass surgery in older adults // Exp. Gerontol. - 2016; 74: 29-36
  5. Rothenburger M., Tjan T., Schneider M. The impact of the pro- and antiinflammatory immune response on ventilation time after cardiac surgery // Cytometry B. Clin. Cytom. - 2013; 53 (1): 70-4
  6. Borgermann J., Lazouski K., Kuhn J. 1,25-Dihydroxyvitamin D fluctuations in cardiac surgery are related to age and clinical outcome // Crit. Care Med. - 2012; 40 (7): 273-81.
  7. Martinez-Comendador J., Alvarez J., Sierra J. Preoperative statin therapy in cardiac surgery is more effective in patients who display preoperative activation of the inflammatory system // Tex Heart Inst. J. - 2013; 40 (1): 42-9.
  8. Willham K., Covinsky K., Widera E. Geriatrics Literature 2017 Year in Review // J. Am. Geriatr. Soc. - 2018; 66 (9): 1665-9.
  9. Skaar E., Eide L., Norekval T. et al. A novel geriatric assessment frailty score predicts 2-year mortality after transcatheter aortic valve implantation // Eur. Heart J. Qual. Care Clin. Outcomes. - 2019; 5 (2): 153-60.
  10. Seco M., Edelman J., Forrest P. et al. Geriatric cardiac surgery: chronology vs. Biology // Heart Lung Circ. - 2014; 23 (9): 794-801.
  11. Partridge J., Harari D., Martin F. et al. Randomized clinical trial of comprehensive geriatric assessment and optimization in vascular surgery // Br. J. Surg. - 2017; 104 (6): 679-87.
  12. Marullo A., Irace F., Vitulli P. et al. Recent Developments in Minimally Invasive Cardiac Surgery: Evolution or Revolution? // Biomed. Res. Int. - 2015; 15: 483-525.
  13. Janssen T., Mosk C., van Hoof-de Lepper C. et al. A multicomponent prehabilitation pathway to reduce the incidence of delirium in elderly patients in need of major abdominal surgery: study protocol for a before-and-after study // BMC Geriatr. - 2019; 19 (1): 87.
  14. Jonker F., Giacovelli J., Muhs B. et al. Trends and outcomes of endovascular and open treatment of thoracic aortic injury // J. Vasc. Surg. - 2010; 51: 565-71.
  15. Ganapathi A., Englum B., Hanna J. et al. Frailty and risk in proximal aortic surgery // J. Thorac. Cardiovasc. Surg. - 2014; 147 (1): 186-91.
  16. Струков В., Елистратов Д., Балыкова Л. и др. Влияние Остеомеда Форте на гормональный статус и течение остеопороза у женщин с дефицитом андрогенов в постменопаузе // Врач. - 2015; 3: 28-32
  17. Струков В., Кислов А., Елистратов Д. и др. Персонифицированный подход в терапии остеопороза у пожилых // Врач. - 2015; 6: 51-3
  18. Струков В.И., Катюшина Ю.Г., Филиппова О.В. Остеомед - эффективный регулятор минеральной плотности костей и закрытия полостных образований при лечении пресенильного и сенильного остеопороза // Поликлиника. - 2013; 1 (1): 90-1
  19. Струков В.И., Елистратов Д.Г. Известные и новые технологии в лечении и профилактике остеопороза. Методические рекомендации / Пенза, 2014; с. 46
  20. Михно Л., Левшин И., Поликарпочкин А. и др. Использование фармакологических средств для сохранения, восстановления и повышения работоспособности юных хоккеистов // Врач. - 2018; 29 (9): 67-71

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies